These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 27999817)
1. EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells Zhao R; Tin L; Zhang Y; Wu Y; Jin Y; Jin X; Zhang F; Li X Biomed Res Int; 2016; 2016():8569684. PubMed ID: 27999817 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma. Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930 [TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog. Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. Zhang P; Bai H; Liu G; Wang H; Chen F; Zhang B; Zeng P; Wu C; Peng C; Huang C; Song Y; Song E Toxicol Lett; 2015 May; 234(3):151-61. PubMed ID: 25725129 [TBL] [Abstract][Full Text] [Related]
5. Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma. Liang Y; Yin D; Hou L; Zheng T; Wang J; Meng X; Lu Z; Song X; Pan S; Jiang H; Liu L PLoS One; 2011; 6(8):e23908. PubMed ID: 21901145 [TBL] [Abstract][Full Text] [Related]
6. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma. Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells. Zhang D; Wang Y; Dong L; Huang Y; Yuan J; Ben W; Yang Y; Ning N; Lu M; Guan Y Cancer Sci; 2013 Dec; 104(12):1690-6. PubMed ID: 24112101 [TBL] [Abstract][Full Text] [Related]
8. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis. Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286 [TBL] [Abstract][Full Text] [Related]
9. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Subramaniam D; May R; Sureban SM; Lee KB; George R; Kuppusamy P; Ramanujam RP; Hideg K; Dieckgraefe BK; Houchen CW; Anant S Cancer Res; 2008 Mar; 68(6):1962-9. PubMed ID: 18339878 [TBL] [Abstract][Full Text] [Related]
10. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis. Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558 [TBL] [Abstract][Full Text] [Related]
11. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018 [TBL] [Abstract][Full Text] [Related]
12. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies. Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816 [TBL] [Abstract][Full Text] [Related]
13. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644 [TBL] [Abstract][Full Text] [Related]
14. Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro. Lu WL; Yang T; Song QJ; Fang ZQ; Pan ZQ; Liang C; Jia DW; Peng PK J Ethnopharmacol; 2019 Apr; 234():204-215. PubMed ID: 30528882 [TBL] [Abstract][Full Text] [Related]
15. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT. Fan X; Song J; Zhao Z; Chen M; Tu J; Lu C; Wu F; Zhang D; Weng Q; Zheng L; Xu M; Ji J Cancer Lett; 2019 Sep; 460():119-127. PubMed ID: 31207322 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway. Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631 [TBL] [Abstract][Full Text] [Related]
17. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687 [TBL] [Abstract][Full Text] [Related]
18. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. Yang CH; Yue J; Sims M; Pfeffer LM PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701 [TBL] [Abstract][Full Text] [Related]
19. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945 [TBL] [Abstract][Full Text] [Related]
20. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]